Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease (ADMIRE-CD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01541579
Recruitment Status : Completed
First Posted : March 1, 2012
Last Update Posted : November 29, 2019
Sponsor:
Information provided by (Responsible Party):
Takeda ( Tigenix S.A.U. )